Data as of Oct 17
| -0.20 / -0.70%|
The 3 analysts offering 12-month price forecasts for Bio-Reference Laboratories Inc have a median target of 34.00, with a high estimate of 42.00 and a low estimate of 32.00. The median estimate represents a +20.40% increase from the last price of 28.24.
The current consensus among 4 polled investment analysts is to Hold stock in Bio-Reference Laboratories Inc. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.